0001968582-24-000518.txt : 20240614 0001968582-24-000518.hdr.sgml : 20240614 20240614160731 ACCESSION NUMBER: 0001968582-24-000518 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240614 DATE AS OF CHANGE: 20240614 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: RxSight, Inc. CENTRAL INDEX KEY: 0001111485 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 943268801 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-40690 FILM NUMBER: 241044776 BUSINESS ADDRESS: STREET 1: 100 COLUMBIA STREET STREET 2: SUITE 120 CITY: ALISO VIEJO STATE: CA ZIP: 92656 BUSINESS PHONE: 949-521-7822 MAIL ADDRESS: STREET 1: 100 COLUMBIA STREET STREET 2: SUITE 120 CITY: ALISO VIEJO STATE: CA ZIP: 92656 FORMER COMPANY: FORMER CONFORMED NAME: CALHOUN VISION INC DATE OF NAME CHANGE: 20000410 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Andrews Julie CENTRAL INDEX KEY: 0001550508 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 5677 AIRLINE ROAD CITY: ARLINGTON STATE: TN ZIP: 38002 144 1 primary_doc.xml 144 0001550508 XXXXXXXX LIVE 0001111485 RxSight, Inc. 001-40690 100 Columbia Street, Suite 120 Aliso Viejo CA 92656 949-521-7822 Julie Andrews Director Common J.P. Morgan Securities LLC

390 Madison Avenue - 6th Floor New York NY 10017

15625 922344 39215324 06/14/2024 NASDAQ Common 07/30/2021 Purchased at IPO Open Market Purchase (NASDAQ) N 15625 07/30/2021 Cash Y 06/14/2024 03/12/2024 /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Julie Andrews